Dexcom [DXCM] vs Medtronic plc [MDT] Detailed Stock Comparison

Dexcom Inc.

NASDAQ
Loading...

Medtronic plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dexcom Inc. wins in 8 metrics, Medtronic plc wins in 12 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dexcom Inc. Medtronic plc Better
P/E Ratio (TTM) 30.03 23.47 Medtronic plc
Price-to-Book Ratio 8.63 2.20 Medtronic plc
Debt-to-Equity Ratio 50.85 57.06 Dexcom Inc.
PEG Ratio 0.39 -1.98 Dexcom Inc.
EV/EBITDA 19.85 13.43 Medtronic plc
Profit Margin (TTM) 17.94% 13.00% Dexcom Inc.
Operating Margin (TTM) 25.64% 20.01% Dexcom Inc.
EBITDA Margin (TTM) 25.64% 20.01% Dexcom Inc.
Return on Equity 34.50% 9.39% Dexcom Inc.
Return on Assets (TTM) 8.89% 4.57% Dexcom Inc.
Free Cash Flow (TTM) $1.08B $5.19B Medtronic plc
Dividend Yield N/A 3.27% N/A
1-Year Return -8.07% -8.10% Dexcom Inc.
Price-to-Sales Ratio (TTM) 5.10 3.04 Medtronic plc
Enterprise Value $23.09B $126.74B Medtronic plc
EV/Revenue Ratio 4.95 3.57 Medtronic plc
Gross Profit Margin (TTM) 62.93% 63.83% Medtronic plc
Revenue per Share (TTM) $12 $28 Medtronic plc
Earnings per Share (Diluted) $2.05 $3.58 Medtronic plc
Beta (Stock Volatility) 1.56 0.76 Medtronic plc
Short % of Float 4.93% 1.33% Medtronic plc

Dexcom Inc. vs Medtronic plc Stock Performance Analysis

Loading Price Chart...

DXCM
MDT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dexcom Inc.-1.53%-3.13%20.43%11.88%12.92%11.54%
Medtronic plc0.22%-0.38%5.55%-8.91%-18.45%-16.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dexcom Inc.-8.07%-42.07%-27.92%315.26%2,149.85%2,129.88%
Medtronic plc-8.10%-10.04%-34.92%-4.68%110.00%59.60%

Performance & Financial Health Analysis: Dexcom Inc. vs Medtronic plc

MetricDXCMMDT
Market Information
Market Cap i$23.76B$107.58B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i4,652,6047,795,730
90 Day Avg. Volume i4,100,8487,987,320
Last Close$74.22$80.38
52 Week Range$54.11 - $89.98$73.31 - $106.33
% from 52W High-17.52%-24.41%
All-Time High$164.86 (Nov 15, 2021)$135.89 (Sep 06, 2021)
% from All-Time High-54.98%-40.85%
Growth Metrics
Quarterly Revenue Growth0.13%0.09%
Quarterly Earnings Growth0.76%-0.12%
Financial Health
Profit Margin (TTM) i0.18%0.13%
Operating Margin (TTM) i0.26%0.20%
Return on Equity (TTM) i0.35%0.09%
Debt to Equity (MRQ) i50.8557.06
Cash & Liquidity
Book Value per Share (MRQ)$7.14$38.17
Cash per Share (MRQ)$5.19$6.53
Operating Cash Flow (TTM) i$1.44B$7.29B
Levered Free Cash Flow (TTM) i$719.54M$4.07B
Dividends
Last 12-Month Dividend Yield iN/A3.27%
Last 12-Month Dividend iN/A$2.80

Valuation & Enterprise Metrics Analysis: Dexcom Inc. vs Medtronic plc

MetricDXCM (Apr 26, 2026)MDT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.0323.47
Forward P/E i20.5913.86
PEG Ratio i0.39-1.98
Price to Sales (TTM) i5.103.04
Price to Book (MRQ) i8.632.20
Market Capitalization
Market Capitalization i$23.76B$107.58B
Enterprise Value i$23.09B$126.74B
Enterprise Value Metrics
Enterprise to Revenue i4.953.57
Enterprise to EBITDA i19.8513.43
Risk & Other Metrics
Beta i1.560.76
Book Value per Share (MRQ) i$7.14$38.17

Financial Statements Comparison: Dexcom Inc. vs Medtronic plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDXCM (2025)MDT (2025)
Revenue/Sales i4.66B33.54B
Cost of Goods Sold i1.86B11.63B
COGS % of Revenue i39.9%34.7%
Gross Profit i2.80B21.91B
Gross Margin i60.1%65.3%
Research & Development i599.10M2.73B
Operating Income (EBIT) i911.80M6.54B
Operating Margin i19.6%19.5%
EBITDA i1.36B9.80B
EBITDA Margin i29.1%29.2%
Pre-Tax Income i1.09B5.63B
Pre-Tax Income % of Revenue i23.3%16.8%
Income Tax i252.10M936.00M
Income Tax % of Revenue i5.4%2.8%
Net Income (Profit) i836.30M4.69B
Profit Margin i17.9%14.0%

Balance Sheet & Liquidity Metrics

MetricDXCM (2025)MDT (2025)
Cash & Equivalents i917.70M2.22B
Total Current Assets i4.03B23.81B
Total Current Assets % of Revenue i86.5%71.0%
Total Current Liabilities i2.14B12.88B
Total Current Liabilities % of Revenue i46.0%38.4%
Long-Term Debt i1.37B25.64B
Long-Term Debt % of Revenue i29.3%76.5%
Total Shareholders Equity i2.75B48.26B
Retained Earnings i2.43B31.48B
Retained Earnings % of Revenue i52.2%93.9%
Property, Plant & Equipment i77.40M7.16B

Cash Flow Statement Comparison

MetricDXCM (2025)MDT (2025)
Operating Cash Flow i1.48B6.71B
Operating Cash Flow % of Revenue i31.7%20.0%
Capital Expenditures i-363.50M-1.86B
Free Cash Flow i1.08B5.19B
FCF Margin i23.1%15.5%
Debt Repayment i-1.21B-1.07B
Common Stock Repurchase i-500.00M-3.24B

Short Interest & Institutional Ownership Analysis

MetricDXCMMDT
Shares Short i14.72M16.98M
Short Ratio i3.772.03
Short % of Float i4.93%1.33%
Shares Outstanding i384.80M1.28B
Float Shares i382.94M1.28B
% Held by Insiders i0.28%0.32%
% Held by Institutions i101.50%88.20%
% Held by Public i-1.78%11.48%

Dividend Analysis & Yield Comparison: Dexcom Inc. vs Medtronic plc

MetricDXCMMDT
Last 12-Month Dividend iN/A$2.80
Last 12-Month Dividend Yield iN/A3.27%
3-Year Avg Annual Dividend iN/A$2.76
3-Year Avg Dividend Yield iN/A0.83%
3-Year Total Dividends iN/A$8.28
Ex-Dividend DateN/AMar 28, 2025